2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Page 2 of 19 4.2 Dose and method of administration PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) EMEND (aprepitant) is available as capsules for oral administration.
Download 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Classified Massage Therapy Research - AMT
www.amt.org.auconcluded that massage therapy appears to be promising for reducing pain intensity/severity, fatigue and anxiety in cancer populations compared to the active comparators evaluated.
AUSTRALIAN CURRICULUM FRAMEWORK FOR …
www.cpmec.org.auConfederation of Postgraduate Medical Education Councils AUSTRALIAN CURRICULUM FRAMEWORK FOR JUNIOR DOCTORS Self-directed learning Identifies and addresses personal learning objectives
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu4.6 Pregnancy and lactation The safety of TachoSil for use in human pregnancy or breastfeeding has not been established in controlled clinical trials.
MaxolonTM - Medicines
www.medicines.org.au2 Young Adults and Children over 1 year of age: The use of Maxolon in patients under 20 years should be restricted to the following situations and only used as second line therapy: Severe intractable vomiting of known cause.
AUSTRALIAN PI APO-METOCLOPRAMIDE …
www.medicines.org.au5 Since metoclopramide hydrochloride monohydrate accelerates abnormally slow gastric and small bowel peristaltic activity, it may change absorption of orally administered drugs.
New Zealand Datasheet Name of Medicine - Medsafe
www.medsafe.govt.nzNew Zealand Datasheet Name of Medicine Ondansetron-DRLA tablets Ondansetron ODT-DRLA tablets Ondansetron hydrochloride dihydrate tablets 4 mg and 8 mg